Innovative cancer research
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.
Showing 641 - 660 of 1397 results
Australian Synchrotron MX2 Upgrade
ANSTO delivers custom tailored radioisotopes bound for space applications with tech incubator entX
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
Work with the Cavendish Laboratory featured in Advanced Energy Materials
PET innovation
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
Research reveals how disordered proteins contribute to the properties of the rabies virus
A large team of international researchers have used synchrotron techniques to understand how key proteins contribute to the virulence of the rabies virus, sometimes called the “zombie virus.”
Technological innovation and partnership needed to make progress on mental disorders
Biologist
Role at ANSTO
Group Executive Nuclear Operations, Safety and Security
In June 2022 Miles was appointed to a new role of Group Executive Nuclear Safety, Security and Stewardship with responsibility for all nuclear safety and security operations at ANSTO as well as coordination of al
Human Activities
Research to identify past human interactions with the environment and clarify information which may result from human impact or responses to changing environments.
Unveiling Sculpture of W. H. Bragg in Adelaide
Radiochemist
Krishant holds a PhD in Medicinal Chemistry, specialising in the design and development of novel platinum(IV)-based anticancer agents, where he has contributed to the development of a new class of compounds that is currently undergoing p
Scientific Officer, Australian Museum
Tara Djokic is a geologist currently based in the Palaeontology Department of the Australian Museum Research Institute where she is investigating the fossilisation processes of an 11-16 million-year-old rainforest-lake deposit from central N
Board Member, Member Risk and Audit Committee
Professor Senden is an accomplished physical chemist and currently is the Pro Vice-Chancellor (Research Infrastructure and Entities) at the Australian National University.
Additional funding for Chronic kidney disease research
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
Research may lead to more effective anti-tumour drug
High intensity X-ray beam provides insights into the activity of natural killer cells.
Using light to understand disease
